Remission of diabetes with glutamic acid decarboxylase antibody positivity that developed after the administration of olanzapine: a case report
Olanzapine is a second-generation antipsychotic drug associated with the development of type 2 diabetes. However, the development and remission of diabetes with glutamic acid decarboxylase (GAD) antibody (Ab) positivity related to olanzapine treatment have not been reported. Here, we present the cas...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Sungkyunkwan University School of Medi
2026-03-01
|
| Schriftenreihe: | Precision and Future Medicine |
| Schlagworte: | |
| Online-Zugang: | http://pfmjournal.org/upload/pdf/pfm-2026-00009.pdf |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|